LaFleur & Godfrey LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
LaFleur & Godfrey LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$404,588
+0.9%
3,9720.0%0.06%
+8.3%
Q2 2023$400,815
-6.7%
3,972
-15.0%
0.06%
-14.3%
Q1 2023$429,824
-4.7%
4,672
-6.0%
0.07%
-6.7%
Q4 2022$451,060
+35.9%
4,972
+13.7%
0.08%
+27.1%
Q3 2022$332,000
-39.5%
4,373
-32.7%
0.06%
-32.2%
Q2 2022$549,000
-3.7%
6,4990.0%0.09%
+13.0%
Q1 2022$570,000
-58.8%
6,499
-59.0%
0.08%
-56.7%
Q4 2021$1,385,000
+3.5%
15,839
-3.2%
0.18%
-3.8%
Q3 2021$1,338,000
-7.6%
16,359
+3.0%
0.18%
-10.6%
Q2 2021$1,448,000
+6.0%
15,881
-0.6%
0.21%
-22.2%
Q1 2021$1,366,000
-19.0%
15,981
-10.6%
0.27%
-22.9%
Q4 2020$1,687,000
-3.0%
17,868
-10.7%
0.34%
-12.2%
Q3 2020$1,740,000
-78.6%
20,010
-78.5%
0.39%
-81.1%
Q2 2020$8,144,000
-0.3%
93,250
-5.8%
2.08%
-14.6%
Q1 2020$8,165,000
+21.4%
99,034
+39.4%
2.43%
+60.2%
Q4 2019$6,727,000
+15.8%
71,039
+6.3%
1.52%
+6.7%
Q3 2019$5,807,000
-9.8%
66,827
-5.2%
1.42%
-11.4%
Q2 2019$6,437,000
-1.4%
70,496
+3.8%
1.61%
-4.7%
Q1 2019$6,529,000
+52.0%
67,916
+35.7%
1.68%
+39.1%
Q4 2018$4,294,000
-0.6%
50,036
-0.2%
1.21%
+16.3%
Q3 2018$4,319,000
+11.2%
50,126
-2.5%
1.04%
+7.2%
Q2 2018$3,885,000
-4.3%
51,435
+2.5%
0.97%
-4.6%
Q1 2018$4,058,000
+3.4%
50,190
+7.4%
1.02%
+5.6%
Q4 2017$3,923,000
+2.1%
46,722
+4.4%
0.96%
-4.2%
Q3 2017$3,841,000
-0.8%
44,744
-3.5%
1.01%
-1.2%
Q2 2017$3,871,000
+12.4%
46,3710.0%1.02%
+9.5%
Q1 2017$3,444,000
-0.3%
46,371
-2.2%
0.93%
-3.9%
Q4 2016$3,455,000
-7.7%
47,4260.0%0.97%
-10.4%
Q3 2016$3,745,000
-4.5%
47,426
-0.2%
1.08%
-7.0%
Q2 2016$3,923,000
+13.9%
47,5410.0%1.16%
+10.9%
Q1 2016$3,444,000
-16.6%
47,541
-1.0%
1.05%
-14.5%
Q4 2015$4,131,000
-8.7%
48,014
-2.5%
1.22%
-9.5%
Q3 2015$4,526,000
-8.3%
49,239
-1.9%
1.35%
-1.0%
Q2 2015$4,936,000
-5.7%
50,193
-5.4%
1.37%
-2.5%
Q1 2015$5,233,000
+5.1%
53,071
-1.2%
1.40%
+5.1%
Q4 2014$4,979,000
-1.2%
53,735
+0.4%
1.33%
-3.5%
Q3 2014$5,040,000
+1.0%
53,540
-2.8%
1.38%
+4.1%
Q2 2014$4,989,000
+2.5%
55,105
-3.8%
1.33%
-1.3%
Q1 2014$4,869,000
+5.0%
57,269
-0.8%
1.34%
+5.2%
Q4 2013$4,638,000
+2.5%
57,707
-2.2%
1.28%
-1.6%
Q3 2013$4,526,000
+8.5%
58,9960.0%1.30%
+4.3%
Q2 2013$4,172,00058,9961.24%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders